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Background: The choice of sampling techniques in bronchoscopy with sampling from a visible
lesion will depend on the expected diagnostic yields and the costs of the sampling techniques.
Aims: The aim of this study was to determine the most economical combination of sampling
techniques when approaching endobronchial visible lesions.
Methods: A cost minimization analysis was performed. All bronchoscopies from 2003 and 2004
at Haukeland university hospital, Bergen, Norway, were reviewed retrospectively for diag-
nostic yields. 162 patients with endobronchial disease were included. Potential sampling tech-
niques used were biopsy, brushing, endobronchial needle aspiration (EBNA) and washings.
Costs were estimated based on registration of equipment costs and personnel costs. Sensitivity
analyses were performed to determine threshold values.
Results: The combination of biopsy, brushing and EBNA was the most economical strategy with an
average cost of Euro 893 (95% CI: 657, 1336). The cost of brushing had to be below Euro 83 and it
had to increase the diagnostic yieldmore than 2.2%, for biopsy and brushing to bemore economical
than biopsy alone. The combination of biopsy, brushing and EBNAwasmore economical than biopsy
and brushing when the cost of EBNA was below Euro 205 and the increase in diagnostic yield was
above 5.2%.
Conclusion: In the current study setting, biopsy, brushingandEBNAwas themost economical combi-
nation of sampling techniques for endobronchial visible lesions.
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Bronchoscopy is the main diagnostic method for endo-
bronchial visible lesions.1e3 A biopsy allows for a histolog-
ical sample, which inherently has more information than
a cytological sample. However, in many instances, a cyto-
logical sample can be sufficient for the establishment of
a malignant diagnosis in the airways, and most physicians
will prefer to take cytological samples in addition to biop-
sies when encountering an endobronchial lesion. The
choices for cytological sampling are brushing, endobron-
chial needle aspiration (EBNA), and washings. The optimal
combination of all sampling techniques is still debated, due
to differences in yield and cost.
Theprevious recommendedcombinationshavebeenbiopsy,
brushing and washing,4e7 biopsy and brushing,8e10 biopsy,
brushing or washing,11,12 biopsy, brushing and EBNA,13e15 or
EBNA alone with rapid on-site cytological evaluation (ROSE)
combined with supplemental techniques if negative.16 So far,
the diagnostic yield has been the most important criterion for
the recommendations. However, the costs of the different
sampling techniques vary greatly, and the overall cost of the
procedurewill in a large part bedependent onhoweach center
organizes its diagnostic procedures. The main weakness of the
current recommendations is the lack of data on true costs.
Although some studies of bronchial washings have included
costs,11,12 the most economical combination of all sampling
techniques has yet not been settled.
The aim of this study was to determine the most
economical combination of sampling techniques in bron-
choscopy of endobronchial visible lesions, using a cost
minimization analysis.
Methods
Study design
The bronchoscopies included in the current study were per-
formed in 2003 and 2004 at Haukeland University Hospital,
Bergen, Norway. Haukeland University Hospital is responsible
for the diagnosis and treatment of lung cancer in a geograph-
ical area comprising 380 000 inhabitants, and serves as
a referral center for surrounding smaller hospitals comprising
950 000 inhabitants. Most patients examined on suspicion of
lung cancer are admitted to a day ward at the hospital.
A total of 1438 bronchoscopies were performed in 2003
and 2004, of which 551 were performed on suspicion of
malignant disease. The sampling and execution of these
investigations, with their diagnostic yields, have been pub-
lished previously.17 For the current study, all 162 patients
with an endobronchial visible lesion deemed suspicious of
malignancy upon inspection were included. The bronchos-
copies were performed by 22 different physicians.Sample collection
The investigations were performed with Olympus BF 1T 160
bronchoscopes, using Boston ‘‘Radial Jaw3’’ for biopsies,
Boston 21 Gauche ‘‘Stifcor’’ transbronchial aspiration
needle for EBNA, and Boston ‘‘Cellebrity’’ for brushings.EBNA was taken directly from the endobronchial lesions.
Washings were performed with aspiration of fluid from the
entire procedure and a sample of the fluid was sent to the
pathological department for investigation. In some cases
small volume lavage (SVL) was performed. However, SVL
was too seldom performed to warrant inclusion in the
current analyses. The physicians determined which sample
techniques to employ, and in which order, during the
bronchoscopies. Thus, not all patients had all possible
sample techniques performed, and the order may vary.
Costs
All costs were transformed to the 2004 NOK value according
to the Consumer Price Index in Norway and transformed to
Euro with the interbank rate of 8.39760 on 01.01.2004.
All available costs for equipment in the department of
thoracic medicine and the department of pathology were
included. The average equipment cost of the bronchoscope
and its cleaningwerebasedonanaverageof715 investigations
yearlyandanaveragedurationofbronchoscopesof7yearsand
average duration time for the washing machine of 10 years.
To estimate the time cost of physicians and nurses in the
bronchoscopy lab, the time consumption of all present
personnel was registered in detail for 24 bronchoscopies.
The personnel costs were calculated based on the median
value for time, the average number of personnel present,
and the average wages per personnel category. The esti-
mates were compared with registration of personnel use in
a larger prospective register in our bronchoscopy lab, and
found to be representative.
The estimation of the personnel cost for examining
biopsies at the department of pathology was based on
a detailed registration of 25 examined samples by the
pathologist. The time consumption in the cytopathology lab
was based on 11 detailed registrations and expert opinion
that assumed that the average time consumption for the
pathology technician was 5 min for preparation of all slides,
and 4 min for investigation of each slide. The time
consumption was based on an average number of slides
examined per sampling technique for the bronchoscopies
performed in 2004.
The average cost of a stay at the day ward was esti-
mated by the average diagnosis related group (DRG) refund
divided by the average days spent in the day ward for
patients admitted in 2007 and adjusted to 2004 value. The
results of the bronchoscopy samplings were presented by
the pathologists at an interdisciplinary meeting every
Friday. The cost of a false negative sample was assumed to
be another five days in the day ward plus the cost of
a repeated bronchoscopy.Cost minimization analysis
A cost effectiveness analysis compares how the increase in
costs of a new clinical strategy compares with the existing
strategy. If the average cost for increased effectiveness is
below the willingness to pay, the new strategy is cost
effective. Usually the effectiveness is measured in quality
adjusted life years (QALY). However, it is difficult tomeasure
a difference in QALY based on the results of bronchoscopy.
Figure 1 Decision tree. The decision tree is based on the diagnostic yield of each combination. The chance nodes represent the
diagnostic yield. When no definite diagnosis is reached the cost of a repeated bronchoscopy and five days in day ward is added.
Table 1 Costs of bronchoscopy, day ward and sampling
techniques.
Euro 2004
value
Estimated 95%
confidence interval
Bronchoscopya 249 200, 298
One day in day ward 421 337, 505
Biopsy 46 37, 56
Brushing 43 35, 52
EBNAb 159 127, 191
Washing 18 15, 22
a The total cost of the actual procedure excluding sampling
costs.
b EBNAZ Endobronchial needle aspiration.
890 K. Roth et al.The cost minimization analysis assumes that the
competing strategies have equivalent outcomes,18 and that
the strategy with the lowest costs is most economical. If
a diagnosis is not reached based on a result from the
bronchoscopy, the standard procedure is to perform
a repeated bronchoscopy. In this study we assumed that
a final diagnosis of visible lesions would be reached in a
maximum of three repeated bronchoscopies. The diag-
nostic yield of a repeated bronchoscopy was assumed to be
in the same range as the first bronchoscopy. Further, for the
purpose of the cost minimization analyses, we assumed
that the second and third bronchoscopy was performed
with the same combination of sampling techniques as in the
first bronchoscopy. The decision tree is displayed in Fig. 1.
The diagnostic yield in the decision tree was based on the
average diagnostic yield for both malignant and benign
lesions. Five actual strategies were included in the analysis.
Biopsy was included in all strategies based on a high diag-
nostic yield compared to costs. Washing was only included
in the strategy with all sampling techniques due to a low
diagnostic yield.
In the model the uncertainty of the costs was modeled
with a beta distribution with the tails three standard
deviations from the mean. 30% deviation represented three
standard deviations.19
Since the aim of this study was to compare differences in
costs between different sampling techniques, costs that
were the same for all strategies were not included in the
analysis, like the costs of blood samples and lung function
tests and the costs for a stay in the day ward for the first
bronchoscopy.
Sensitivity analyses were performed to find threshold
values. Threshold values represent the values that willchange the most economical strategy. In one way sensitivity
analyses all variables are constant except the actual vari-
able that is analyzed. By increasing or decreasing the value
of the variable being analyzed, the threshold value will
appear when there is a change in which strategy that is
most economical.
Statistical analysis
All effectiveness data were analyzed in SPSS version 13.20
The cost minimization analysis was performed in TreeAge
Pro Health Care 2007.21 The confidence intervals were
calculated with Monte Carlo simulations with 1000 simula-
tions. The threshold values for different strategies were
found by rebuilding the decision tree with two branches.
The Regional Norwegian Ethical Committee and the
Norwegian Social Science Data Service approved the study.
Table 2 Average total time consumption for handling the different samples by all involved personnel, and average wage per
personnel category.
Average time
consumption (min)a
Average number
of employees
Average wages/hour
(Euro 2004 value)
Cost
(Euro 2004 value)
Biopsy
Equipment cost 16
Senior physician 5 1.0 67 6
Junior physician 5 0.9 54 4
Nurses 5 2.1 31 5
Pathologist 7 1.0 69 8
Pathology technician 10 1.0 31 5
Secretary 5 1.0 26 2
Brushing
Equipment cost 12
Senior physician 3 1.0 67 3
Junior physician 3 0.9 54 2
Nurses 3 2.1 31 3
Pathologist 3 1.0 69 3
Pathology technician 32 1.0 31 16
Secretary 5 1.0 26 2
EBNAb
Equipment cost 82
Senior physician 16 1.0 67 18
Junior physician 16 0.9 54 13
Nurses 16 2.1 31 17
Pathologist 6 1.0 69 7
Pathology technician 40 1.0 31 20
Secretary 5 1.0 26 2
Washing
Equipment cost 3
Senior physician 1 1.0 67 1
Junior physician 1 0.9 54 1
Nurses 1 2.1 31 1
Pathologist 3 1.0 69 3
Pathology technician 13 1.0 31 7
Secretary 5 1.0 26 2
a The time consumption in the bronchoscopy lab was based on 24 registries. The time consumption in the pathology department was
based on 25 registrations for histopathology, and 11 registrations and expert opinion for cytopathology.
b EBNAZ Endobronchial needle aspiration.
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Of the 162 patients in the study, 64 were women. Malignant
disease was diagnosed in 154 patients, of which 36 (23.4%)Table 3 Diagnostic yield for bronchoscopy of endobronchial vis
Malignant disease
n DYa (%)
Biopsy 127 0.787
Biopsy and brushing 50 0.820
Biopsy and EBNAb 94 0.840
Biopsy brushing and EBNA 41 0.902
Biopsy, brushing, EBNA
and washing
41 0.902
All patients 154 0.766
a DYZ Diagnostic yield. Data are presented as number of positive s
b EBNAZ Endobronchial needle aspiration.had small cell lung cancer, 98 (63.6%) non-small cell lung
cancer (14 adenocarcinoma, 44 squamous cell carcinoma
and 40 other non-small cell carcinoma). Five (3.2%) of the
patients had a carcinoid tumor, seven (4.5%) had lungible lesions by different sampling techniques.
Benign disease Overall diagnostic yield
n DY (%) n DY (%)
5 0 132 0.758
2 0 52 0.788
4 0 98 0.806
2 0 43 0.860
2 0 43 0.860
8 0 162 0.728
amples/all samples (%).
Table 4 The median cost for the different strategies
(base case analysis).
Median
Euro
Estimated 95%
CI
Biopsy alone 999 751, 1331
Biopsy and brushing 970 637, 1471
Biopsy and EBNAa 1040 795, 1385
Biopsy, brushing and EBNA 893 621, 1336
Biopsy, brushing, EBNA and
Washing
924 623, 1367
All values are in Euro 2004 value.
a EBNAZ Endobronchial needle aspiration.
892 K. Roth et al.metastases and three (1.9%) had lymphoma. Five patients
had a final malignant diagnosis based on follow-up. Of the
eight patients with benign disease, one patient had
a granulation polyp, one patient had oropharyngeal cancer
but samples from the lung did not show malignancy, one
patient had a polyp with squamous cell metaplasia, four
patients had lesions suspicious of malignancy but proven
benign at follow-up, and one patient had a benign lesion
below the vocal cords.
The average costs of a stay for one day at the day ward,
a bronchoscopy and for each sampling technique are dis-
played in Table 1. EBNA was the most expensive sampling
technique; more than three times as expensive as a biopsy,
and almost nine times as expensive as washings.
The time consumption for the different employees and
their average wages are shown in Table 2. In 90% of the
procedures, an additional junior physician was present,
while for all procedures, an average of 2.1 nurses was
present, irrespective of combination of sampling
techniques.
Table 3 presents the diagnostic yield from the combi-
nation of sampling techniques employed in each of the five
strategies. Note that among the 162 patients, biopsy was
taken in 132 patients, brushing in 66, EBNA in 116, and
washing in 158. Biopsy had sensitivity for cancer of 78.7%
(Table 3). None of the benign cases were definitely diag-
nosed by bronchoscopy. Thus, the overall diagnostic yield
for biopsy was 75.8% for benign and malignant disease
combined. Brushing increased the overall diagnostic yield
to 78.8%. Biopsy, brushing and EBNA had an overallTable 5 Threshold values from one way sensitivity analyses.
Biopsy and brushing
more economical
than biopsy alone
Biopsy,
more e
biopsy
Cost of brushing <Euro 83
Cost of EBNA <Euro
Cost of washing
Cost of one day at a
day ward
>Euro 189 >Euro
Minimum increase in
diagnostic yield
2.2% 5.2%
All values are in Euro 2004 value.
a EBNAZ Endobronchial needle aspiration.diagnostic yield of 86.0%. Washing did not increase the
diagnostic yield when biopsy, brushing and EBNA was per-
formed (Table 3).
Based on the total costs and diagnostic yields for each
strategy, the median cost was found to be Euro 893 (95% CI:
621, 1336) for biopsy, brushing and EBNA, compared to Euro
970 (637, 1471) for biopsy and brushing, and Euro 999 (751,
1331) for biopsy alone (Table 4).
Sensitivity analysis
The threshold values for one way sensitivity analysis are
shown in Table 5. The combination of brushing and biopsy
was dependent on an overall diagnostic yield for benign and
malignant disease of minimum 78.0% or a cost of brushings
below Euro 83 to be more economical than biopsy alone. If
the diagnostic yield of biopsy, brushing and EBNA was above
84.0%, or the cost of EBNA was below Euro 205 the triple
combination was more economical than biopsy and brush-
ing. When the average cost of the stay in the day ward was
below Euro 189, biopsy alone was most economical,
between Euro 189 and Euro 311 biopsy and brushing was
more economical, above Euro 311 biopsy, brushing and
EBNA was most economical, based on the assumption that
a missed diagnosis would increase the cost with five days in
day ward. Biopsy, brushing and EBNA was more economical
than biopsy and brushing when the costs of a repeated
bronchoscopy including five days in day ward were above
Euro 1786.
Discussion
In this study, the combination of biopsy, brushing and EBNA
in one procedure was the most economical strategy for
diagnosing endobronchial lesions, with an average cost of
Euro 893 compared to Euro 970 for biopsy and brushing and
Euro 999 for biopsy alone.
The main strength of this study was the application of an
analysis that involved costs in the comparison of different
diagnostic yields. The results and the threshold values
should be comparable to other institutions.
There are some methodological issues to consider.
Firstly, all sampling techniques were applied simulta-
neously in only 43 of 162 cases. The choice of combinations
of sampling techniques was left to the investigator. If it wasbrushing, and EBNAa
conomical than
and brushing
Biopsy, brushing, EBNA, and
washing more economical than
biopsy, brushing, and EBNA
205
No threshold value found
311 No threshold values found.
1.0%
Cost minimization analysis of visible lung lesions 893difficult to reach a lesion, fewer sampling techniques might
have been applied, thus overestimating the diagnostic
value of multiple sampling techniques. On the other hand,
some investigators would perhaps use more sampling
techniques in hard-to-reach-lesions.
Secondly, the sample size of this study was too small to
allow adjustment for the size of the lesion or the location.
Thirdly, in prospective studies it would be possible to
collect data about all costs for each patient. In a retrospec-
tive study such as this, the costs must be based on a model
with average costs for each procedure, which is less precise.
In this study the model for costs was based on registra-
tion of the time consumption for different health workers in
the bronchoscopy lab and in the department of pathology.
The time consumption is not constant and the variation was
only included in the assumption that the costs were in
a range of a 30% deviation. The time consumption in the
cytopathology lab was based on expert opinion, prone to
information bias. These assumptions and uncertainties of
costs must be considered, especially when comparing to
costs reported in other studies.
EBNA is the most costly sampling technique. However,
prolonging the stay at the day ward and having a new
procedure performed is much more costly. Thus, adding
EBNA to all procedures seems warranted from the modeling
in this study, since this prevented a large enough number of
repeated procedures to be less costly overall. Whether this
would be true for other centers will depend upon the local
diagnostic yield for each procedure, and the organization of
the diagnostic work-flow until conclusion.
The effectiveness of different combinations of sampling
techniques has been an issue in previous studies.4e16 In the
current study, the combination of biopsy and brushing was
more economical than biopsy alone given that the diagnostic
yield for the combination was at least 78.0% compared to the
diagnostic yield of biopsy alone of 75.8%. Previous studies
have reported that brushing increased sensitivity for cancer
above 2.2% compared to biopsy alone.5,8,11,14,15,22,23
Compared to the diagnostic yield of biopsy andbrushing of
78.8%, the combination of biopsy, brushing and EBNA was
most economical in the current study if the diagnostic yield
was above 84.0%. Fewprevious studies have included EBNA in
the analyses. Three studies reported increased sensitivity for
EBNA above 5.2% compared to biopsy and brushing.13e15
Given the diagnostic yields in the current study, the cost
of brushing had to be below Euro 83, if biopsy and brushing
should be more economical than biopsy alone. One previous
study had a price of brushing below this threshold value,12
while in the other study the price of brushing was above this
threshold value.11 The cost of EBNA had to be below Euro
205, for the combination of biopsy, brushing and EBNA to be
more economical than biopsy and brushing. Only one study
included EBNA; with a price below the threshold value.12
Although the current study recommends biopsy, brushing
and EBNA in one procedure, the results must be interpreted
cautiously. Some institutions investigate the patients as
outpatients to a much larger degree than ours. If the cost of
a repeated bronchoscopy including the cost of the delay is
below Euro 1786, biopsy and brushing without EBNA might
be a more economical choice for an outpatient investiga-
tion. In countries where the cost for the waiting time is low,
biopsy alone might be most economical.Aspiration of fluid from the entire procedure for wash-
ings did not increase the diagnostic yield regardless, and
has been omitted in our hospital for the investigations of
visible lesions.
For the clinical decision maker the optimal combination
of sampling techniques will be based on the willingness to
pay for increased diagnostic yield. A great increase may
warrant the extra costs of more sampling techniques as that
would save the time and cost for a new procedure. If
a center knows its own diagnostic yields for the different
sampling techniques, a sensitivity analysis can reveal the
threshold values for when a given technique becomes
economical. It is important to emphasize that the current
analysis is economical in nature, and does not take into
account the psychological burden of time to diagnosis. We
do not advocate to prolong the investigative time to
decrease costs. On the contrary, the analyses show that
even though the increased diagnostic yield was small with
added sampling techniques employed, it saved money due
to the high cost of diagnostic delay.
For the diagnosis of lung cancer, each diagnostic center
will have slightly different results. The costs will vary with
different practices and models of financial support. Thus,
we recommend all centers, both excellent and regular, to
calculate both their diagnostic yields, and the costs of their
diagnostic work-ups, and finally to publish these results.
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